Kanagawa, Japan

Yoshiyuki Fujimura

This inventor holds 1 USPTO granted patent. Top assignee: Mitsubishi Kasei Corporation. Active years: 1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yoshiyuki Fujimura. Retrieved from https://idiyas.com/inventor/yoshiyuki-fujimura-93c7q906

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1996

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Yoshiyuki Fujimura

Introduction

Yoshiyuki Fujimura is a notable inventor based in Kanagawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his work on sulfonamide derivatives. His innovative approach has the potential to address various serious health conditions.

Latest Patents

Fujimura holds a patent for sulfonamide derivatives, which exhibit strong inhibitory activity against cysteine proteases such as calpain, papain, cathepsin B, cathepsin H, and cathepsin L. These compounds can be utilized as remedies for muscular dystrophy, cataracts, myocardial infarction, strokes, Alzheimer's disease, amyotrophia, osteoporosis, and hypercalcemia. This patent highlights his commitment to advancing medical treatments.

Career Highlights

Yoshiyuki Fujimura is associated with Mitsubishi Kasei Corporation, where he has been able to apply his expertise in developing innovative pharmaceutical solutions. His work has garnered attention for its potential impact on healthcare.

Collaborations

Fujimura has collaborated with esteemed colleagues such as Ryoichi Ando and Chizuko Takahashi. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Yoshiyuki Fujimura's contributions to the field of medicinal chemistry through his innovative patents demonstrate his dedication to improving health outcomes. His work continues to inspire advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…